Biotechnology
The Biotechnology industry has a total of 592 stocks, with a combined market cap of $1.11 trillion and total revenue of $110.18 billion.
Market Cap
1.11T
Revenue
110.18B
Profits
-39.69B
PE Ratio
n/a
Profit Margin
-36.02%
Dividend Yield
0.04%
592 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 110.47B | -1.01% | 948,862 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 78.30B | 0.16% | 460,419 | 14.34B |
| 3 | ARGX | argenx SE | 46.37B | 0.25% | 314,689 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 43.81B | 3.60% | 1,276,807 | 3.71B |
| 5 | INSM | Insmed Incorporated | 35.36B | 0.85% | 1,852,747 | 606.42M |
| 6 | ONC | BeOne Medicines AG | 33.54B | -2.67% | 202,265 | 5.34B |
| 7 | RPRX | Royalty Pharma plc | 27.30B | -2.57% | 2,765,977 | 2.38B |
| 8 | BNTX | BioNTech SE | 23.08B | 0.11% | 466,665 | 3.37B |
| 9 | ROIV | Roivant Sciences Ltd. | 19.95B | -1.59% | 5,824,554 | 13.31M |
| 10 | MRNA | Moderna, Inc. | 19.34B | -0.87% | 3,488,547 | 1.94B |
| 11 | RVMD | Revolution Medicines, Inc. | 18.90B | -3.79% | 1,743,881 | - |
| 12 | INCY | Incyte Corporation | 18.88B | -1.12% | 998,001 | 5.14B |
| 13 | GMAB | Genmab A/S | 16.77B | 0.91% | 1,242,656 | 3.72B |
| 14 | SMMT | Summit Therapeutics Inc. | 14.49B | -3.56% | 1,947,798 | - |
| 15 | BBIO | BridgeBio Pharma, Inc. | 14.01B | -1.19% | 630,775 | 502.08M |
| 16 | ASND | Ascendis Pharma A/S | 13.91B | -1.12% | 368,814 | 845.52M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.28B | -0.62% | 1,440,940 | 943.71M |
| 18 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.25B | -2.38% | 293,934 | 958.40M |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 11.50B | -0.05% | 1,218,464 | 4.27B |
| 20 | EXEL | Exelixis, Inc. | 11.42B | 0.23% | 1,723,204 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.81B | 1.28% | 1,859,495 | 3.22B |
| 22 | ABVX | ABIVAX Société Anonyme | 9.27B | 0.93% | 298,351 | 5.37M |
| 23 | AXSM | Axsome Therapeutics, Inc. | 8.68B | 0.73% | 337,511 | 638.50M |
| 24 | PRAX | Praxis Precision Medicines, Inc. | 8.64B | -0.09% | 304,228 | 7.46M |
| 25 | PCVX | Vaxcyte, Inc. | 8.61B | 2.47% | 1,019,522 | - |
| 26 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.56B | 0.15% | 1,202,323 | 1.09B |
| 27 | TECH | Bio-Techne Corporation | 8.42B | 1.26% | 1,746,125 | 1.22B |
| 28 | NUVL | Nuvalent, Inc. | 8.15B | -1.63% | 766,350 | - |
| 29 | CYTK | Cytokinetics, Incorporated | 8.00B | -2.68% | 1,314,252 | 88.04M |
| 30 | KRYS | Krystal Biotech, Inc. | 7.65B | 0.33% | 238,419 | 389.13M |
| 31 | HALO | Halozyme Therapeutics, Inc. | 7.47B | -2.19% | 1,541,655 | 1.40B |
| 32 | IBRX | ImmunityBio, Inc. | 7.31B | -3.01% | 13,321,775 | 113.29M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 6.96B | -0.15% | 434,158 | 39.21M |
| 34 | BLTE | Belite Bio, Inc | 6.73B | 0.78% | 208,140 | - |
| 35 | ACLX | Arcellx, Inc. | 6.73B | -0.04% | 663,230 | 22.29M |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 6.57B | -0.86% | 528,510 | 46.02M |
| 37 | APGE | Apogee Therapeutics, Inc. | 6.20B | -0.39% | 626,907 | - |
| 38 | CNTA | Centessa Pharmaceuticals plc | 6.14B | -0.05% | 2,372,463 | 15.00M |
| 39 | TERN | Terns Pharmaceuticals, Inc. | 6.09B | 0.11% | 6,133,246 | - |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.94B | 0.78% | 535,141 | 189.76M |
| 41 | MIRM | Mirum Pharmaceuticals, Inc. | 5.81B | 2.20% | 494,287 | 521.31M |
| 42 | COGT | Cogent Biosciences, Inc. | 5.70B | 0.60% | 1,363,225 | - |
| 43 | CGON | CG Oncology, Inc. | 5.70B | 0.10% | 1,141,586 | 4.04M |
| 44 | PTCT | PTC Therapeutics, Inc. | 5.70B | 1.67% | 770,402 | 1.73B |
| 45 | SRRK | Scholar Rock Holding Corporation | 5.61B | -2.40% | 1,275,580 | - |
| 46 | CELC | Celcuity Inc. | 5.52B | 1.41% | 851,343 | - |
| 47 | XENE | Xenon Pharmaceuticals Inc. | 5.42B | -0.02% | 1,652,571 | 7.50M |
| 48 | CAI | Caris Life Sciences, Inc. | 5.37B | -1.45% | 1,572,633 | 812.03M |
| 49 | ERAS | Erasca, Inc. | 5.32B | -3.87% | 5,250,953 | - |
| 50 | APLS | Apellis Pharmaceuticals, Inc. | 5.19B | 0.54% | 6,084,003 | 1.00B |
| 51 | IMVT | Immunovant, Inc. | 5.07B | 1.59% | 1,151,924 | - |
| 52 | TGTX | TG Therapeutics, Inc. | 4.98B | 0.48% | 2,051,553 | 616.29M |
| 53 | CRSP | CRISPR Therapeutics AG | 4.72B | -0.73% | 1,145,482 | 3.51M |
| 54 | FOLD | Amicus Therapeutics, Inc. | 4.54B | 0.07% | 2,310,703 | 634.21M |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 4.53B | -0.58% | 1,047,252 | 2.04M |
| 56 | CORT | Corcept Therapeutics Incorporated | 4.35B | -3.86% | 1,022,117 | 761.41M |
| 57 | LGND | Ligand Pharmaceuticals Incorporated | 4.06B | 2.01% | 234,908 | 268.09M |
| 58 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.95B | 1.26% | 905,567 | 7.70M |
| 59 | VKTX | Viking Therapeutics, Inc. | 3.93B | -2.50% | 2,394,115 | - |
| 60 | NAMS | NewAmsterdam Pharma Company N.V. | 3.92B | 3.43% | 1,129,424 | 22.50M |
| 61 | SYRE | Spyre Therapeutics, Inc. | 3.85B | 2.94% | 791,810 | - |
| 62 | ACAD | ACADIA Pharmaceuticals Inc. | 3.81B | 0.54% | 1,298,586 | 1.07B |
| 63 | GPCR | Structure Therapeutics Inc. | 3.67B | -3.20% | 977,467 | - |
| 64 | EWTX | Edgewise Therapeutics, Inc. | 3.52B | -1.50% | 577,238 | - |
| 65 | LEGN | Legend Biotech Corporation | 3.45B | -2.40% | 774,733 | 1.03B |
| 66 | DNLI | Denali Therapeutics Inc. | 3.07B | -6.15% | 1,801,194 | - |
| 67 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.05B | 1.17% | 822,195 | 588.99M |
| 68 | TLX | Telix Pharmaceuticals Limited | 3.03B | -0.44% | 61,183 | 803.79M |
| 69 | DYN | Dyne Therapeutics, Inc. | 3.03B | -2.60% | 1,311,454 | - |
| 70 | TARS | Tarsus Pharmaceuticals, Inc. | 2.99B | 0.10% | 545,344 | 451.36M |
| 71 | TVTX | Travere Therapeutics, Inc. | 2.94B | 4.57% | 2,949,961 | 490.73M |
| 72 | ARQT | Arcutis Biotherapeutics, Inc. | 2.93B | 0.11% | 1,391,214 | 376.07M |
| 73 | TNGX | Tango Therapeutics, Inc. | 2.90B | -6.20% | 2,035,600 | 62.38M |
| 74 | VERA | Vera Therapeutics, Inc. | 2.89B | -1.02% | 1,393,801 | - |
| 75 | IDYA | IDEAYA Biosciences, Inc. | 2.84B | -1.22% | 553,832 | 218.71M |
| 76 | ORKA | Oruka Therapeutics, Inc. | 2.79B | 5.74% | 1,928,388 | - |
| 77 | ALMS | Alumis Inc. | 2.79B | -6.12% | 1,622,663 | 24.05M |
| 78 | RCUS | Arcus Biosciences, Inc. | 2.79B | -3.14% | 655,032 | 247.00M |
| 79 | SLNO | Soleno Therapeutics, Inc. | 2.70B | 32.31% | 58,038,094 | 190.41M |
| 80 | IRON | Disc Medicine, Inc. | 2.51B | 0.98% | 425,595 | - |
| 81 | AAPG | Ascentage Pharma Group International | 2.44B | 0.33% | 4,254 | 82.08M |
| 82 | IMNM | Immunome, Inc. | 2.43B | -1.65% | 731,796 | 6.94M |
| 83 | CLDX | Celldex Therapeutics, Inc. | 2.41B | 1.00% | 1,918,681 | 1.55M |
| 84 | KOD | Kodiak Sciences Inc. | 2.41B | -4.01% | 990,643 | - |
| 85 | BEAM | Beam Therapeutics Inc. | 2.41B | -1.74% | 1,298,496 | 139.74M |
| 86 | SRPT | Sarepta Therapeutics, Inc. | 2.39B | -1.85% | 2,257,987 | 2.20B |
| 87 | MANE | Veradermics, Incorporated | 2.38B | -0.58% | 226,132 | - |
| 88 | ELVN | Enliven Therapeutics, Inc. | 2.33B | 0.28% | 706,120 | - |
| 89 | MLYS | Mineralys Therapeutics, Inc. | 2.33B | 4.67% | 1,557,252 | - |
| 90 | ZLAB | Zai Lab Limited | 2.31B | 0.44% | 499,500 | 460.16M |
| 91 | RARE | Ultragenyx Pharmaceutical Inc. | 2.24B | 1.87% | 1,352,288 | 673.00M |
| 92 | RLAY | Relay Therapeutics, Inc. | 2.23B | -0.72% | 5,435,245 | 15.36M |
| 93 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | 0.05% | 907,860 | 158.18M |
| 94 | ADMA | ADMA Biologics, Inc. | 2.21B | 0.98% | 3,848,186 | 510.17M |
| 95 | ADPT | Adaptive Biotechnologies Corporation | 2.17B | -4.93% | 1,440,849 | 276.98M |
| 96 | NKTR | Nektar Therapeutics | 2.14B | -2.95% | 451,791 | 55.23M |
| 97 | SNDX | Syndax Pharmaceuticals, Inc. | 2.14B | -3.42% | 1,735,262 | 172.35M |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 2.13B | 2.50% | 1,358,147 | 283.06M |
| 99 | TYRA | Tyra Biosciences, Inc. | 2.10B | -1.72% | 1,204,948 | - |
| 100 | AGIO | Agios Pharmaceuticals, Inc. | 2.04B | -1.14% | 1,068,723 | 54.03M |
| 101 | DFTX | Definium Therapeutics, Inc. | 2.04B | -1.21% | 1,168,682 | - |
| 102 | GLPG | Galapagos NV | 1.95B | -0.07% | 97,085 | 1.31B |
| 103 | STOK | Stoke Therapeutics, Inc. | 1.94B | 0.15% | 529,192 | 184.42M |
| 104 | ZYME | Zymeworks Inc. | 1.91B | 0.16% | 383,587 | 105.97M |
| 105 | MESO | Mesoblast Limited | 1.90B | 0.41% | 102,774 | 65.38M |
| 106 | PHVS | Pharvaris N.V. | 1.86B | -0.67% | 290,917 | - |
| 107 | CAPR | Capricor Therapeutics, Inc. | 1.82B | -1.34% | 847,345 | 11.13M |
| 108 | ANAB | AnaptysBio, Inc. | 1.79B | 8.24% | 440,180 | 234.60M |
| 109 | OCUL | Ocular Therapeutix, Inc. | 1.76B | -4.95% | 3,080,140 | 51.95M |
| 110 | VCEL | Vericel Corporation | 1.74B | -0.18% | 409,243 | 276.26M |
| 111 | PVLA | Palvella Therapeutics, Inc. | 1.72B | -2.92% | 267,352 | - |
| 112 | INVA | Innoviva, Inc. | 1.70B | 0.13% | 451,860 | 411.33M |
| 113 | SION | Sionna Therapeutics, Inc. | 1.68B | -7.68% | 191,854 | - |
| 114 | RXRX | Recursion Pharmaceuticals, Inc. | 1.66B | 1.29% | 8,413,536 | 74.68M |
| 115 | TRVI | Trevi Therapeutics, Inc. | 1.64B | 7.29% | 1,804,340 | - |
| 116 | NRIX | Nurix Therapeutics, Inc. | 1.63B | 1.81% | 1,682,603 | 83.98M |
| 117 | IMCR | Immunocore Holdings plc | 1.62B | 3.60% | 648,746 | 400.02M |
| 118 | HRMY | Harmony Biosciences Holdings, Inc. | 1.60B | -0.11% | 683,188 | 868.45M |
| 119 | NTLA | Intellia Therapeutics, Inc. | 1.57B | 1.29% | 1,943,375 | 67.67M |
| 120 | OCS | Oculis Holding AG | 1.56B | -1.09% | 139,184 | 1.51M |
| 121 | RAPP | Rapport Therapeutics, Inc. | 1.55B | -3.57% | 221,110 | - |
| 122 | GENB | Generate Biomedicines, Inc. | 1.54B | -12.00% | 385,403 | 31.89M |
| 123 | NBTX | Nanobiotix S.A. | 1.53B | 5.54% | 22,388 | 38.27M |
| 124 | NUVB | Nuvation Bio Inc. | 1.53B | 0.91% | 3,083,034 | 62.90M |
| 125 | MBX | MBX Biosciences, Inc. | 1.49B | -5.12% | 436,509 | - |
| 126 | PGEN | Precigen, Inc. | 1.48B | 6.35% | 3,706,862 | 9.68M |
| 127 | DMRA | Damora Therapeutics, Inc. | 1.48B | -2.07% | 167,126 | - |
| 128 | ARDX | Ardelyx, Inc. | 1.46B | 0.51% | 1,576,571 | 407.32M |
| 129 | VIR | Vir Biotechnology, Inc. | 1.45B | - | 1,356,454 | 68.56M |
| 130 | MAZE | Maze Therapeutics, Inc. | 1.44B | 1.01% | 550,648 | 2.50M |
| 131 | VRDN | Viridian Therapeutics, Inc. | 1.42B | -26.22% | 14,520,523 | 70.85M |
| 132 | SVRA | Savara Inc. | 1.42B | 0.72% | 1,338,513 | - |
| 133 | ATAI | AtaiBeckley Inc. | 1.40B | 1.58% | 3,365,456 | 4.09M |
| 134 | IMTX | Immatics N.V. | 1.38B | -0.39% | 368,532 | 56.67M |
| 135 | BHVN | Biohaven Ltd. | 1.38B | -6.63% | 1,683,154 | - |
| 136 | BCAX | Bicara Therapeutics Inc. | 1.36B | -2.89% | 552,051 | - |
| 137 | IOVA | Iovance Biotherapeutics, Inc. | 1.36B | -3.79% | 9,803,818 | 263.50M |
| 138 | GLUE | Monte Rosa Therapeutics, Inc. | 1.35B | -0.94% | 705,104 | 123.67M |
| 139 | TSHA | Taysha Gene Therapies, Inc. | 1.34B | 6.41% | 4,244,529 | 9.77M |
| 140 | WVE | Wave Life Sciences Ltd. | 1.33B | -2.61% | 2,894,998 | 42.73M |
| 141 | ZBIO | Zenas BioPharma, Inc. | 1.32B | 3.73% | 643,037 | 10.00M |
| 142 | OLMA | Olema Pharmaceuticals, Inc. | 1.32B | 0.73% | 870,415 | - |
| 143 | NVAX | Novavax, Inc. | 1.30B | 3.51% | 2,798,633 | 1.12B |
| 144 | CRVS | Corvus Pharmaceuticals, Inc. | 1.24B | 0.14% | 624,659 | - |
| 145 | MLTX | MoonLake Immunotherapeutics | 1.22B | -2.19% | 1,019,484 | - |
| 146 | DBVT | DBV Technologies S.A. | 1.17B | -3.32% | 159,696 | 5.64M |
| 147 | PHAR | Pharming Group N.V. | 1.16B | -0.72% | 11,280 | 376.13M |
| 148 | GERN | Geron Corporation | 1.12B | 5.42% | 39,279,050 | 183.88M |
| 149 | SEPN | Septerna, Inc. | 1.11B | -1.59% | 140,164 | 45.95M |
| 150 | AVBP | ArriVent BioPharma, Inc. | 1.10B | 0.32% | 180,269 | - |
| 151 | EYPT | EyePoint, Inc. | 1.09B | -2.16% | 869,295 | 31.37M |
| 152 | QURE | uniQure N.V. | 1.09B | 1.34% | 1,040,392 | 16.10M |
| 153 | XERS | Xeris Biopharma Holdings, Inc. | 1.04B | 0.17% | 893,181 | 291.85M |
| 154 | IVA | Inventiva S.A. | 1.04B | 3.66% | 1,015,354 | 9.31M |
| 155 | KALV | KalVista Pharmaceuticals, Inc. | 1.03B | 1.46% | 1,298,536 | 73.62M |
| 156 | ABCL | AbCellera Biologics Inc. | 1.03B | -3.69% | 3,206,879 | 75.13M |
| 157 | MPLT | MapLight Therapeutics, Inc. | 995.38M | 6.80% | 226,539 | - |
| 158 | CMPX | Compass Therapeutics, Inc. | 988.68M | 0.73% | 3,197,513 | 850.00K |
| 159 | CTMX | CytomX Therapeutics, Inc. | 951.18M | -3.51% | 3,722,886 | 76.20M |
| 160 | GHRS | GH Research PLC | 939.13M | 3.91% | 143,208 | - |
| 161 | INBX | Inhibrx Biosciences, Inc. | 930.76M | 0.30% | 147,571 | 1.30M |
| 162 | ANNX | Annexon, Inc. | 930.75M | 5.45% | 3,338,035 | - |
| 163 | XNCR | Xencor, Inc. | 912.33M | -2.89% | 864,662 | 125.58M |
| 164 | JANX | Janux Therapeutics, Inc. | 908.82M | 0.67% | 1,346,998 | 10.00M |
| 165 | URGN | UroGen Pharma Ltd. | 905.98M | -1.12% | 442,767 | 109.79M |
| 166 | AKTS | Aktis Oncology, Inc. | 904.87M | -5.76% | 375,471 | 6.50M |
| 167 | CGEM | Cullinan Therapeutics, Inc. | 903.05M | 3.40% | 1,055,980 | - |
| 168 | ORIC | ORIC Pharmaceuticals, Inc. | 894.19M | 0.22% | 2,440,009 | - |
| 169 | PHAT | Phathom Pharmaceuticals, Inc. | 886.49M | -0.79% | 584,195 | 175.11M |
| 170 | EVMN | Evommune, Inc. | 885.33M | 3.63% | 151,888 | 13.00M |
| 171 | VOR | Vor Biopharma Inc. | 881.60M | -9.86% | 1,484,508 | - |
| 172 | ABUS | Arbutus Biopharma Corporation | 871.83M | -0.45% | 696,187 | 14.08M |
| 173 | SANA | Sana Biotechnology, Inc. | 859.31M | 0.63% | 1,744,232 | - |
| 174 | FTRE | Fortrea Holdings Inc. | 842.44M | -4.66% | 1,197,871 | 2.72B |
| 175 | SPRY | ARS Pharmaceuticals, Inc. | 833.10M | 1.08% | 1,142,349 | 84.28M |
| 176 | TBPH | Theravance Biopharma, Inc. | 829.04M | 0.50% | 522,174 | 107.46M |
| 177 | SLS | SELLAS Life Sciences Group, Inc. | 813.51M | 9.69% | 5,359,400 | - |
| 178 | JBIO | Jade Biosciences, Inc. | 797.44M | 4.39% | 694,705 | - |
| 179 | MNKD | MannKind Corporation | 788.74M | 2.40% | 3,175,560 | 348.97M |
| 180 | OMER | Omeros Corporation | 783.68M | -0.14% | 1,029,376 | - |
| 181 | MGTX | MeiraGTx Holdings plc | 775.37M | 3.70% | 1,129,666 | 81.39M |
| 182 | DSGN | Design Therapeutics, Inc. | 772.75M | 11.58% | 719,352 | - |
| 183 | SLDB | Solid Biosciences Inc. | 761.55M | 3.34% | 947,208 | - |
| 184 | MRVI | Maravai LifeSciences Holdings, Inc. | 758.35M | - | 1,678,405 | 185.74M |
| 185 | SGP | SpyGlass Pharma, Inc. | 757.11M | 0.85% | 123,610 | - |
| 186 | KURA | Kura Oncology, Inc. | 749.92M | -1.39% | 838,326 | 67.48M |
| 187 | TENX | Tenax Therapeutics, Inc. | 748.47M | -0.93% | 834,773 | - |
| 188 | DRUG | Bright Minds Biosciences Inc. | 732.20M | 4.93% | 164,248 | - |
| 189 | RLMD | Relmada Therapeutics, Inc. | 723.74M | -1.29% | 682,675 | - |
| 190 | ANRO | Alto Neuroscience, Inc. | 719.73M | 3.92% | 346,598 | - |
| 191 | ARVN | Arvinas, Inc. | 717.64M | 3.41% | 1,164,707 | 262.60M |
| 192 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 713.09M | - | 519,322 | - |
| 193 | REPL | Replimune Group, Inc. | 705.17M | 1.55% | 3,217,715 | - |
| 194 | LBRX | LB Pharmaceuticals Inc | 681.56M | 4.87% | 411,695 | - |
| 195 | LXRX | Lexicon Pharmaceuticals, Inc. | 673.65M | - | 1,587,079 | 49.80M |
| 196 | GYRE | Gyre Therapeutics, Inc. | 650.16M | - | 78,233 | 116.59M |
| 197 | CBIO | Crescent Biopharma, Inc. | 643.69M | -0.10% | 245,018 | 10.84M |
| 198 | ALLO | Allogene Therapeutics, Inc. | 633.82M | 4.84% | 3,277,145 | 22.00K |
| 199 | DRTS | Alpha Tau Medical Ltd. | 601.11M | -1.30% | 221,995 | - |
| 200 | OCGN | Ocugen, Inc. | 598.08M | -1.12% | 4,408,013 | 4.41M |
| 201 | PRME | Prime Medicine, Inc. | 591.45M | 0.60% | 2,149,976 | 4.63M |
| 202 | MDXG | MiMedx Group, Inc. | 576.44M | -1.02% | 940,162 | 418.63M |
| 203 | ZURA | Zura Bio Limited | 574.98M | 0.50% | 1,284,658 | - |
| 204 | ZVRA | Zevra Therapeutics, Inc. | 571.85M | 3.62% | 911,923 | 106.47M |
| 205 | AGMB | AgomAb Therapeutics NV | 570.22M | 9.14% | 105,616 | - |
| 206 | TECX | Tectonic Therapeutic, Inc. | 562.92M | -1.77% | 168,424 | - |
| 207 | CRMD | CorMedix Inc. | 559.68M | 0.43% | 825,759 | 311.71M |
| 208 | PROK | ProKidney Corp. | 546.47M | -4.74% | 673,407 | 893.00K |
| 209 | VALN | Valneva SE | 543.61M | -2.30% | 26,376 | 205.07M |
| 210 | KYTX | Kyverna Therapeutics, Inc. | 542.89M | 1.24% | 544,584 | - |
| 211 | PRTA | Prothena Corporation plc | 540.48M | 1.83% | 412,514 | 9.68M |
| 212 | UPB | Upstream Bio, Inc. | 528.96M | 2.32% | 502,190 | 2.85M |
| 213 | ACRS | Aclaris Therapeutics, Inc. | 528.18M | -9.52% | 2,011,786 | 7.83M |
| 214 | LRMR | Larimar Therapeutics, Inc. | 524.61M | 5.43% | 2,007,126 | - |
| 215 | FULC | Fulcrum Therapeutics, Inc. | 521.48M | -2.61% | 756,595 | 80.00M |
| 216 | EIKN | Eikon Therapeutics, Inc. | 511.07M | -4.65% | 369,573 | - |
| 217 | FDMT | 4D Molecular Therapeutics, Inc. | 507.45M | 4.85% | 460,176 | 85.21M |
| 218 | LYEL | Lyell Immunopharma, Inc. | 505.53M | 2.26% | 60,911 | 36.00K |
| 219 | RIGL | Rigel Pharmaceuticals, Inc. | 505.42M | -0.62% | 202,941 | 294.28M |
| 220 | CTNM | Contineum Therapeutics, Inc. | 501.80M | - | 124,368 | - |
| 221 | YDES | YD Bio Limited | 500.89M | -4.13% | 11,496 | 510.36K |
| 222 | TRDA | Entrada Therapeutics, Inc. | 499.68M | 5.55% | 197,381 | 25.42M |
| 223 | FBRX | Forte Biosciences, Inc. | 496.23M | 3.36% | 151,914 | - |
| 224 | VTVT | vTv Therapeutics Inc. | 490.67M | -3.96% | 49,169 | 17.00K |
| 225 | STTK | Shattuck Labs, Inc. | 485.21M | 5.61% | 420,698 | 1.00M |
| 226 | ENGN | enGene Holdings Inc. | 485.00M | 8.22% | 218,199 | - |
| 227 | VSTM | Verastem, Inc. | 481.34M | -2.66% | 1,315,188 | 30.91M |
| 228 | AVIR | Atea Pharmaceuticals, Inc. | 467.68M | 1.91% | 478,569 | - |
| 229 | ADCT | ADC Therapeutics SA | 466.25M | -2.91% | 629,823 | 81.36M |
| 230 | ASMB | Assembly Biosciences, Inc. | 463.51M | 0.72% | 114,945 | 72.30M |
| 231 | IMMX | Immix Biopharma, Inc. | 454.97M | -3.91% | 544,226 | - |
| 232 | RGNX | REGENXBIO Inc. | 454.19M | 3.17% | 560,351 | 170.44M |
| 233 | ABSI | Absci Corporation | 452.94M | -3.27% | 4,515,558 | 2.80M |
| 234 | EPRX | Eupraxia Pharmaceuticals Inc. | 437.01M | -0.98% | 128,565 | - |
| 235 | ALT | Altimmune, Inc. | 433.25M | -0.30% | 2,360,635 | 41.00K |
| 236 | AURA | Aura Biosciences, Inc. | 428.53M | 2.14% | 545,202 | - |
| 237 | LXEO | Lexeo Therapeutics, Inc. | 427.48M | 0.87% | 5,256,624 | - |
| 238 | NAUT | Nautilus Biotechnology, Inc. | 423.99M | 1.36% | 197,221 | - |
| 239 | VNDA | Vanda Pharmaceuticals Inc. | 411.98M | -0.43% | 769,048 | 216.11M |
| 240 | XOMA | XOMA Royalty Corporation | 402.16M | 2.33% | 119,542 | 52.15M |
| 241 | DNA | Ginkgo Bioworks Holdings, Inc. | 399.88M | -0.43% | 841,110 | 170.16M |
| 242 | STRO | Sutro Biopharma, Inc. | 396.79M | 0.71% | 153,780 | 102.48M |
| 243 | IPSC | Century Therapeutics, Inc. | 393.59M | 2.82% | 1,521,812 | 109.16M |
| 244 | ARMP | Armata Pharmaceuticals, Inc. | 386.48M | 3.63% | 116,672 | 4.90M |
| 245 | NMRA | Neumora Therapeutics, Inc. | 385.93M | 6.00% | 1,706,598 | - |
| 246 | ENTA | Enanta Pharmaceuticals, Inc. | 384.51M | 0.84% | 115,598 | 66.98M |
| 247 | LCTX | Lineage Cell Therapeutics, Inc. | 383.59M | -1.91% | 1,253,296 | 14.56M |
| 248 | BNTC | Benitec Biopharma Inc. | 376.46M | 0.64% | 77,452 | - |
| 249 | RCKT | Rocket Pharmaceuticals, Inc. | 375.65M | -2.54% | 2,745,781 | - |
| 250 | AVTX | Avalo Therapeutics, Inc. | 370.77M | -8.39% | 1,097,863 | 59.00K |
| 251 | XFOR | X4 Pharmaceuticals, Inc. | 370.04M | -4.01% | 231,992 | 35.11M |
| 252 | AUTL | Autolus Therapeutics plc | 369.94M | -1.42% | 1,298,226 | 75.39M |
| 253 | CADL | Candel Therapeutics, Inc. | 367.70M | 0.40% | 1,532,717 | - |
| 254 | IVVD | Invivyd, Inc. | 367.37M | 1.56% | 3,222,891 | 53.43M |
| 255 | PRTC | PureTech Health plc | 364.17M | -0.13% | 3,077 | 6.39M |
| 256 | MNPR | Monopar Therapeutics Inc. | 358.72M | -2.63% | 180,333 | - |
| 257 | NAGE | Niagen Bioscience, Inc. | 358.71M | 2.05% | 516,726 | 129.42M |
| 258 | DMAC | DiaMedica Therapeutics Inc. | 356.70M | 2.16% | 142,607 | - |
| 259 | NGEN | NervGen Pharma Corp. | 353.97M | 3.05% | 263,754 | - |
| 260 | PBYI | Puma Biotechnology, Inc. | 350.54M | -0.14% | 346,466 | 228.37M |
| 261 | IMRX | Immuneering Corporation | 349.13M | -0.92% | 656,389 | - |
| 262 | BCYC | Bicycle Therapeutics plc | 340.87M | -3.17% | 458,881 | 72.59M |
| 263 | RZLT | Rezolute, Inc. | 338.62M | 4.49% | 1,291,772 | - |
| 264 | CABA | Cabaletta Bio, Inc. | 335.08M | 1.69% | 3,287,275 | - |
| 265 | ANL | Adlai Nortye Ltd. | 332.10M | 10.02% | 480,075 | -1.35M |
| 266 | IRD | Opus Genetics, Inc. | 328.00M | 1.32% | 778,761 | 14.20M |
| 267 | PALI | Palisade Bio, Inc. | 323.12M | 2.12% | 3,099,896 | - |
| 268 | CLYM | Climb Bio, Inc. | 321.96M | 2.74% | 320,082 | - |
| 269 | NGNE | Neurogene Inc. | 318.81M | -1.06% | 100,322 | 925.00K |
| 270 | SRZN | Surrozen, Inc. | 314.74M | -1.69% | 67,392 | 3.48M |
| 271 | GLSI | Greenwich LifeSciences, Inc. | 305.22M | -3.46% | 101,655 | - |
| 272 | IKT | Inhibikase Therapeutics, Inc. | 305.06M | -0.56% | 692,791 | 1.00 |
| 273 | PRLD | Prelude Therapeutics Incorporated | 303.73M | 6.36% | 391,152 | 12.14M |
| 274 | OVID | Ovid Therapeutics Inc. | 303.31M | 4.55% | 5,848,776 | 7.25M |
| 275 | LENZ | LENZ Therapeutics, Inc. | 301.32M | -0.62% | 463,676 | 19.09M |
| 276 | FHTX | Foghorn Therapeutics Inc. | 286.46M | -1.01% | 126,924 | 30.91M |
| 277 | ADAG | Adagene Inc. | 285.43M | 8.27% | 499,142 | 7.67M |
| 278 | NBP | NovaBridge Biosciences | 279.00M | -0.41% | 338,298 | - |
| 279 | CCCC | C4 Therapeutics, Inc. | 277.12M | 0.71% | 1,485,968 | 35.95M |
| 280 | AVXL | Anavex Life Sciences Corp. | 274.31M | -1.00% | 1,004,775 | - |
| 281 | TARA | Protara Therapeutics, Inc. | 274.21M | -0.78% | 411,009 | - |
| 282 | SLN | Silence Therapeutics plc | 273.96M | -2.36% | 259,685 | 559.00K |
| 283 | ABEO | Abeona Therapeutics Inc. | 271.55M | -1.24% | 1,002,609 | 5.82M |
| 284 | PLYX | Polaryx Therapeutics, Inc. | 271.28M | -19.75% | 447,804 | - |
| 285 | SABS | SAB Biotherapeutics, Inc. | 270.56M | -0.77% | 251,150 | 114.70K |
| 286 | ACIU | AC Immune SA | 267.84M | -2.17% | 171,421 | 4.51M |
| 287 | EDIT | Editas Medicine, Inc. | 266.21M | 1.87% | 1,932,738 | 40.52M |
| 288 | HELP | Cybin Inc. | 263.19M | 2.73% | 792,526 | - |
| 289 | CLLS | Cellectis S.A. | 260.21M | 0.88% | 32,891 | 79.59M |
| 290 | ALEC | Alector, Inc. | 258.80M | -2.70% | 582,331 | 21.05M |
| 291 | ALXO | ALX Oncology Holdings Inc. | 257.95M | -0.51% | 674,694 | - |
| 292 | CHRS | Coherus Oncology, Inc. | 250.32M | -3.47% | 620,552 | 42.17M |
| 293 | CNTX | Context Therapeutics Inc. | 248.99M | -0.37% | 442,995 | - |
| 294 | OBIO | Orchestra BioMed Holdings, Inc. | 248.13M | -0.70% | 132,707 | 33.48M |
| 295 | SLGL | Sol-Gel Technologies Ltd. | 243.02M | -6.44% | 63,648 | 19.39M |
| 296 | VYGR | Voyager Therapeutics, Inc. | 236.61M | 0.25% | 816,296 | 40.37M |
| 297 | ELDN | Eledon Pharmaceuticals, Inc. | 234.74M | 0.65% | 1,365,635 | - |
| 298 | KROS | Keros Therapeutics, Inc. | 234.05M | -1.08% | 437,394 | 244.06M |
| 299 | ARCT | Arcturus Therapeutics Holdings Inc. | 233.64M | 2.37% | 385,453 | 82.03M |
| 300 | CAMP | Camp4 Therapeutics Corporation | 233.12M | 0.45% | 69,070 | 3.50M |
| 301 | NERV | Minerva Neurosciences, Inc. | 226.33M | -0.95% | 231,755 | - |
| 302 | OABI | OmniAb, Inc. | 222.97M | - | 294,897 | 18.67M |
| 303 | FENC | Fennec Pharmaceuticals Inc. | 221.33M | - | 126,939 | 44.64M |
| 304 | MDWD | MediWound Ltd. | 212.32M | -1.73% | 224,289 | 16.96M |
| 305 | ENLV | Enlivex Ltd. | 207.38M | -8.24% | 329,270 | - |
| 306 | CGEN | Compugen Ltd. | 206.13M | -3.54% | 379,565 | 72.76M |
| 307 | NVCT | Nuvectis Pharma, Inc. | 202.66M | 1.19% | 77,833 | - |
| 308 | MGNX | MacroGenics, Inc. | 202.11M | 3.58% | 1,035,570 | 149.50M |
| 309 | ABOS | Acumen Pharmaceuticals, Inc. | 199.31M | 2.22% | 544,464 | - |
| 310 | KRRO | Korro Bio, Inc. | 198.89M | -1.50% | 754,689 | 6.39M |
| 311 | ELTX | Elicio Therapeutics, Inc. | 196.29M | 0.19% | 100,679 | - |
| 312 | TNXP | Tonix Pharmaceuticals Holding Corp. | 193.34M | -2.09% | 207,006 | 13.11M |
| 313 | ZNTL | Zentalis Pharmaceuticals, Inc. | 190.80M | 2.28% | 491,917 | 26.87M |
| 314 | PRQR | ProQR Therapeutics N.V. | 190.70M | 5.85% | 899,260 | 19.19M |
| 315 | MENS | Jyong Biotech Ltd. | 189.94M | 0.82% | 124,636 | - |
| 316 | CRBU | Caribou Biosciences, Inc. | 188.44M | 0.52% | 633,075 | 11.16M |
| 317 | MIST | Milestone Pharmaceuticals Inc. | 186.43M | 10.14% | 2,700,291 | 1.55M |
| 318 | CNTN | Canton Strategic Holdings, Inc. | 184.13M | -0.31% | 326,047 | - |
| 319 | ARTV | Artiva Biotherapeutics, Inc. | 180.18M | 8.16% | 351,413 | 251.00K |
| 320 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 179.85M | -0.29% | 268,118 | - |
| 321 | PLX | Protalix BioTherapeutics, Inc. | 178.06M | 2.79% | 651,365 | 52.74M |
| 322 | ACHV | Achieve Life Sciences, Inc. | 171.97M | - | 437,944 | - |
| 323 | CDXS | Codexis, Inc. | 171.74M | 3.85% | 1,320,201 | 70.39M |
| 324 | GALT | Galectin Therapeutics Inc. | 168.52M | -4.12% | 534,277 | - |
| 325 | NKTX | Nkarta, Inc. | 168.25M | 1.72% | 431,127 | - |
| 326 | SGMT | Sagimet Biosciences Inc. | 167.49M | -3.38% | 183,324 | - |
| 327 | UNCY | Unicycive Therapeutics, Inc. | 167.07M | -4.47% | 708,680 | - |
| 328 | RNAC | Cartesian Therapeutics, Inc. | 165.42M | -0.32% | 92,948 | 2.80M |
| 329 | WHWK | Whitehawk Therapeutics, Inc. | 165.19M | -0.28% | 274,461 | 7.15M |
| 330 | TLSA | Tiziana Life Sciences Ltd | 163.36M | 2.40% | 126,033 | - |
| 331 | CNTB | Connect Biopharma Holdings Limited | 161.65M | -4.35% | 428,415 | 64.00K |
| 332 | DTIL | Precision BioSciences, Inc. | 155.08M | 3.26% | 196,881 | 34.26M |
| 333 | HRTX | Heron Therapeutics, Inc. | 152.81M | 1.41% | 1,424,992 | 154.90M |
| 334 | IMUX | Immunic, Inc. | 152.64M | 0.86% | 1,715,898 | - |
| 335 | MOLN | Molecular Partners AG | 151.17M | 4.94% | 396 | 856.30K |
| 336 | SPRO | Spero Therapeutics, Inc. | 151.10M | 7.41% | 478,895 | 66.80M |
| 337 | CBUS | Cibus, Inc. | 145.49M | -3.54% | 440,808 | 3.64M |
| 338 | AGEN | Agenus Inc. | 144.76M | 13.21% | 1,855,787 | 114.20M |
| 339 | HUMA | Humacyte, Inc. | 144.31M | 1.18% | 5,229,850 | 2.04M |
| 340 | KLRS | Kalaris Therapeutics, Inc. | 143.76M | 8.29% | 129,855 | - |
| 341 | BDTX | Black Diamond Therapeutics, Inc. | 143.22M | 4.60% | 616,607 | 70.00M |
| 342 | TNYA | Tenaya Therapeutics, Inc. | 143.22M | -4.98% | 3,020,972 | - |
| 343 | KPTI | Karyopharm Therapeutics Inc. | 142.47M | 7.30% | 538,614 | 146.07M |
| 344 | ORMP | Oramed Pharmaceuticals Inc. | 139.13M | 0.58% | 61,839 | 2.00M |
| 345 | FATE | Fate Therapeutics, Inc. | 138.35M | -2.46% | 852,816 | 6.65M |
| 346 | NTHI | NeOnc Technologies Holdings, Inc. | 136.65M | -3.53% | 37,752 | 39.99K |
| 347 | ACOG | Alpha Cognition Inc. | 134.80M | 3.68% | 52,978 | 10.22M |
| 348 | EQ | Equillium, Inc. | 127.09M | 2.03% | 241,165 | 4.39M |
| 349 | PEPG | PepGen Inc. | 125.79M | 5.20% | 1,923,403 | - |
| 350 | IPHA | Innate Pharma S.A. | 125.73M | 1.46% | 20,560 | 10.57M |
| 351 | GNLX | Genelux Corporation | 121.14M | 6.23% | 327,988 | 8.00K |
| 352 | ANTX | AN2 Therapeutics, Inc. | 121.12M | 3.06% | 227,199 | - |
| 353 | SGMO | Sangamo Therapeutics, Inc. | 115.42M | -7.16% | 6,174,505 | 39.55M |
| 354 | ONCY | Oncolytics Biotech Inc. | 110.32M | -1.07% | 453,669 | - |
| 355 | BMEA | Biomea Fusion, Inc. | 109.17M | -1.95% | 1,352,972 | - |
| 356 | CRDF | Cardiff Oncology, Inc. | 108.02M | - | 615,465 | 593.00K |
| 357 | LONA | LeonaBio, Inc. | 103.23M | -3.17% | 44,077 | - |
| 358 | VRCA | Verrica Pharmaceuticals Inc. | 102.73M | 9.32% | 75,393 | 35.58M |
| 359 | PMN | ProMIS Neurosciences, Inc. | 98.29M | -12.39% | 170,106 | - |
| 360 | TTRX | Turn Therapeutics Inc. | 98.05M | -0.60% | 43,717 | - |
| 361 | SEER | Seer, Inc. | 96.48M | 0.59% | 45,802 | 16.58M |
| 362 | COYA | Coya Therapeutics, Inc. | 95.00M | 1.00% | 191,447 | 7.95M |
| 363 | VANI | Vivani Medical, Inc. | 93.96M | 2.78% | 159,716 | - |
| 364 | ALDX | Aldeyra Therapeutics, Inc. | 92.68M | -7.23% | 2,049,475 | - |
| 365 | INO | Inovio Pharmaceuticals, Inc. | 92.20M | - | 3,035,549 | 65.34K |
| 366 | HURA | TuHURA Biosciences, Inc. | 92.19M | 2.84% | 1,739,692 | - |
| 367 | PYXS | Pyxis Oncology, Inc. | 91.11M | -2.03% | 232,923 | 13.86M |
| 368 | AARD | Aardvark Therapeutics, Inc. | 90.10M | -3.95% | 227,162 | - |
| 369 | ANIX | Anixa Biosciences, Inc. | 86.84M | 1.57% | 76,202 | - |
| 370 | SPRB | Spruce Biosciences, Inc. | 86.45M | -10.62% | 49,333 | 697.00K |
| 371 | EXOZ | eXoZymes, Inc. | 85.21M | 14.99% | 12,420 | -700.00 |
| 372 | MCRB | Seres Therapeutics, Inc. | 84.46M | -4.96% | 23,787 | 789.00K |
| 373 | KZIA | Kazia Therapeutics Limited | 83.87M | - | 72,330 | 1.27M |
| 374 | NRXS | NeurAxis, Inc. | 82.90M | 2.21% | 190,467 | 3.57M |
| 375 | RANI | Rani Therapeutics Holdings, Inc. | 82.78M | -1.16% | 917,306 | 1.63M |
| 376 | QTTB | Q32 Bio Inc. | 82.51M | -11.60% | 277,517 | 53.74M |
| 377 | OKYO | OKYO Pharma Limited | 82.39M | -6.55% | 46,216 | - |
| 378 | PTHS | Pelthos Therapeutics Inc. | 81.81M | 19.51% | 28,717 | 16.80M |
| 379 | CSBR | Champions Oncology, Inc. | 81.79M | 2.08% | 4,519 | 57.95M |
| 380 | GOSS | Gossamer Bio, Inc. | 81.18M | -6.51% | 9,805,153 | 48.47M |
| 381 | FLNA | Filana Therapeutics, Inc. | 81.16M | -2.89% | 265,935 | - |
| 382 | PLRX | Pliant Therapeutics, Inc. | 81.11M | -2.96% | 519,963 | - |
| 383 | PYPD | PolyPid Ltd. | 80.91M | -3.42% | 37,769 | - |
| 384 | ATYR | aTyr Pharma, Inc. | 80.79M | -2.70% | 729,175 | 190.00K |
| 385 | GANX | Gain Therapeutics, Inc. | 78.57M | 0.54% | 521,170 | - |
| 386 | MAIA | MAIA Biotechnology, Inc. | 78.27M | -3.01% | 769,212 | - |
| 387 | FBIO | Fortress Biotech, Inc. | 77.91M | -3.46% | 697,579 | 63.26M |
| 388 | CGTX | Cognition Therapeutics, Inc. | 74.85M | -3.49% | 872,831 | - |
| 389 | NRXP | NRx Pharmaceuticals, Inc. | 74.33M | 2.27% | 693,090 | 1.23M |
| 390 | ACET | Adicet Bio, Inc. | 74.17M | -1.29% | 78,312 | - |
| 391 | COEP | Coeptis Therapeutics Holdings, Inc. | 72.75M | -2.42% | 53,349 | 1.36M |
| 392 | GUTS | Fractyl Health, Inc. | 72.50M | 0.24% | 1,006,021 | 3.00K |
| 393 | CING | Cingulate Inc. | 72.10M | 0.98% | 310,588 | - |
| 394 | XBIT | XBiotech Inc. | 70.73M | -1.28% | 19,675 | - |
| 395 | BYSI | BeyondSpring Inc. | 70.31M | -0.87% | 9,819 | 1.88M |
| 396 | IBIO | iBio, Inc. | 70.12M | 2.53% | 501,681 | 300.00K |
| 397 | MNOV | MediciNova, Inc. | 69.40M | -2.08% | 15,514 | 409.66K |
| 398 | PMVP | PMV Pharmaceuticals, Inc. | 69.33M | -2.99% | 424,969 | - |
| 399 | IBO | Impact BioMedical Inc. | 69.01M | 8.36% | 196,051 | 32.00K |
| 400 | IFRX | InflaRx N.V. | 68.20M | 3.40% | 1,238,926 | 34.44K |
| 401 | DWTX | Dogwood Therapeutics, Inc. | 68.14M | -3.32% | 96,932 | - |
| 402 | ANVS | Annovis Bio, Inc. | 66.63M | 3.07% | 1,349,870 | - |
| 403 | GRCE | Grace Therapeutics, Inc. | 62.98M | -20.66% | 1,700,042 | - |
| 404 | ACRV | Acrivon Therapeutics, Inc. | 60.83M | 3.29% | 876,337 | - |
| 405 | ATHE | Alterity Therapeutics Limited | 60.16M | 1.35% | 3,206 | 4.43M |
| 406 | ICCC | ImmuCell Corporation | 59.80M | 2.64% | 28,697 | 27.64M |
| 407 | OKUR | OnKure Therapeutics, Inc. | 59.48M | 1.40% | 181,425 | - |
| 408 | TCRX | TScan Therapeutics, Inc. | 59.18M | 2.97% | 806,234 | 10.33M |
| 409 | ESLA | Estrella Immunopharma, Inc. | 58.02M | 29.52% | 694,590 | - |
| 410 | TIL | Instil Bio, Inc. | 57.38M | 5.35% | 66,074 | - |
| 411 | INKT | MiNK Therapeutics, Inc. | 56.81M | 7.02% | 89,470 | - |
| 412 | HYFT | MindWalk Holdings Corp. | 56.12M | -0.88% | 317,488 | 20.70M |
| 413 | ENTX | Entera Bio Ltd. | 55.48M | -5.56% | 279,091 | 42.00K |
| 414 | KZR | Kezar Life Sciences, Inc. | 54.55M | - | 123,212 | - |
| 415 | OSTX | OS Therapies Incorporated | 53.39M | -6.62% | 792,052 | - |
| 416 | RADX | Radiopharm Theranostics Limited | 51.41M | 0.45% | 43,027 | 10.86M |
| 417 | MGX | Metagenomi Therapeutics, Inc. | 51.16M | 0.74% | 166,608 | 25.21M |
| 418 | IMA | ImageneBio, Inc. | 50.89M | -8.45% | 13,355 | 800.00K |
| 419 | HOWL | Werewolf Therapeutics, Inc. | 50.54M | 2.97% | 739,712 | 1.14M |
| 420 | MREO | Mereo BioPharma Group plc | 50.47M | -1.19% | 1,397,496 | 500.00K |
| 421 | ALGS | Aligos Therapeutics, Inc. | 50.06M | 1.51% | 58,706 | 2.19M |
| 422 | NBY | NovaBay Pharmaceuticals, Inc. | 50.06M | -3.59% | 317,164 | 10.30M |
| 423 | ACTU | Actuate Therapeutics, Inc. | 49.79M | -15.32% | 137,101 | - |
| 424 | XLO | Xilio Therapeutics, Inc. | 48.92M | -0.59% | 27,802 | 43.77M |
| 425 | EDSA | Edesa Biotech, Inc. | 48.59M | -5.21% | 182,908 | - |
| 426 | NTRB | Nutriband Inc. | 45.34M | 2.75% | 5,455 | 2.28M |
| 427 | LSTA | Lisata Therapeutics, Inc. | 45.16M | -0.40% | 91,639 | 170.00K |
| 428 | IMMP | Immutep Limited | 44.84M | -0.41% | 231,184 | 5.28M |
| 429 | SNSE | Sensei Biotherapeutics, Inc. | 44.74M | 7.61% | 33,366 | - |
| 430 | TELO | Telomir Pharmaceuticals, Inc. | 44.70M | 2.36% | 25,710 | - |
| 431 | ATOS | Atossa Therapeutics, Inc. | 44.35M | -4.10% | 54,708 | - |
| 432 | PDSB | PDS Biotechnology Corporation | 43.56M | 22.90% | 1,767,393 | - |
| 433 | RLYB | Rallybio Corporation | 42.95M | -3.68% | 122,713 | 858.00K |
| 434 | RNXT | RenovoRx, Inc. | 41.98M | -4.91% | 297,406 | 1.12M |
| 435 | LITS | Lite Strategy, Inc. | 41.45M | 1.79% | 204,391 | - |
| 436 | CELU | Celularity Inc. | 40.37M | 5.26% | 57,164 | 40.58M |
| 437 | ATRA | Atara Biotherapeutics, Inc. | 39.83M | -2.40% | 53,401 | 120.77M |
| 438 | NXTC | NextCure, Inc. | 39.27M | 2.89% | 39,324 | - |
| 439 | RNTX | Rein Therapeutics Inc. | 38.97M | 14.88% | 236,065 | - |
| 440 | VERU | Veru Inc. | 38.52M | 4.80% | 96,686 | 16.89M |
| 441 | HYPD | Hyperion DeFi, Inc. | 37.59M | 1.54% | 179,566 | 813.46K |
| 442 | CRVO | CervoMed Inc. | 36.85M | -3.86% | 30,749 | 4.01M |
| 443 | CVM | CEL-SCI Corporation | 34.96M | 24.50% | 99,352 | - |
| 444 | ABVC | ABVC BioPharma, Inc. | 34.35M | 27.52% | 565,915 | 797.92K |
| 445 | ATNM | Actinium Pharmaceuticals, Inc. | 33.98M | 11.18% | 345,617 | 90.00K |
| 446 | PTN | Palatin Technologies, Inc. | 33.64M | 1.75% | 10,441 | 8.96M |
| 447 | PLUR | Pluri Inc. | 32.77M | -1.81% | 815 | 1.34M |
| 448 | INMB | INmune Bio Inc. | 32.70M | 1.65% | 302,938 | 50.00K |
| 449 | LGVN | Longeveron Inc. | 32.21M | 2.80% | 633,743 | 1.20M |
| 450 | DYAI | Dyadic International, Inc. | 31.52M | -2.80% | 36,319 | 3.09M |
| 451 | BCTX | BriaCell Therapeutics Corp. | 31.41M | 5.37% | 93,941 | - |
| 452 | EVAX | Evaxion A/S | 31.07M | -1.46% | 15,847 | 7.53M |
| 453 | APLM | Apollomics, Inc. | 30.06M | -4.89% | 1,663 | 6.93M |
| 454 | SNTI | Senti Biosciences, Inc. | 28.41M | 6.52% | 64,917 | 22.00K |
| 455 | KYNB | Kyntra Bio, Inc. | 28.25M | -0.43% | 5,799 | 6.44M |
| 456 | PASG | Passage Bio, Inc. | 28.10M | 8.42% | 32,292 | - |
| 457 | TVRD | Tvardi Therapeutics, Inc. | 27.96M | -1.32% | 44,615 | - |
| 458 | NRSN | NeuroSense Therapeutics Ltd. | 26.94M | -8.19% | 283,080 | - |
| 459 | SER | Serina Therapeutics, Inc. | 26.48M | 1.42% | 356,995 | 130.00K |
| 460 | BOLD | Boundless Bio, Inc. | 26.44M | 9.26% | 303,992 | - |
| 461 | LEXX | Lexaria Bioscience Corp. | 26.38M | 1.92% | 368,665 | 522.00K |
| 462 | DARE | Daré Bioscience, Inc. | 26.35M | 4.02% | 53,068 | 1.03M |
| 463 | IGC | IGC Pharma, Inc. | 25.69M | 1.13% | 359,790 | 1.11M |
| 464 | XCUR | Exicure, Inc. | 25.62M | -4.06% | 9,093 | 500.00K |
| 465 | LIXT | Lixte Biotechnology Holdings, Inc. | 25.09M | -5.57% | 43,980 | - |
| 466 | SKYE | Skye Bioscience, Inc. | 23.85M | 2.35% | 184,623 | - |
| 467 | MRKR | Marker Therapeutics, Inc. | 23.51M | 6.82% | 264,186 | 3.55M |
| 468 | NEUP | Neuphoria Therapeutics Inc. | 23.29M | -2.04% | 55,590 | 14.99M |
| 469 | BRNS | Barinthus Biotherapeutics plc | 23.23M | -5.23% | 8,435 | 14.97M |
| 470 | AEON | AEON Biopharma, Inc. | 23.03M | 2.39% | 117,202 | - |
| 471 | PSTV | Plus Therapeutics, Inc. | 22.85M | -6.46% | 552,328 | 5.21M |
| 472 | TPST | Tempest Therapeutics, Inc. | 22.81M | - | 181,447 | - |
| 473 | NNVC | NanoViricides, Inc. | 21.81M | 8.57% | 235,088 | - |
| 474 | VTGN | Vistagen Therapeutics, Inc. | 21.50M | -7.50% | 569,966 | 789.00K |
| 475 | CRIS | Curis, Inc. | 21.31M | -3.07% | 372,095 | 9.44M |
| 476 | OTLK | Outlook Therapeutics, Inc. | 20.99M | -8.40% | 2,654,144 | 205.70K |
| 477 | TVGN | Tevogen Bio Holdings Inc. | 20.72M | 11.55% | 23,558 | - |
| 478 | COCP | Cocrystal Pharma, Inc. | 20.68M | -0.66% | 4,406,406 | - |
| 479 | QNTM | Quantum BioPharma Ltd. | 20.31M | -10.05% | 264,405 | - |
| 480 | VYNE | VYNE Therapeutics Inc. | 20.12M | 0.45% | 170,757 | 570.00K |
| 481 | PLRZ | Polyrizon Ltd. | 19.95M | 1.82% | 40,521 | - |
| 482 | KTTA | Pasithea Therapeutics Corp. | 19.78M | 3.01% | 182,354 | - |
| 483 | CTXR | Citius Pharmaceuticals, Inc. | 19.24M | 0.67% | 256,729 | 3.94M |
| 484 | JSPR | Jasper Therapeutics, Inc. | 19.16M | -0.54% | 1,282,560 | - |
| 485 | ALLR | Allarity Therapeutics, Inc. | 18.67M | 1.72% | 183,704 | 320.00K |
| 486 | ICU | SeaStar Medical Holding Corporation | 18.29M | 6.26% | 346,344 | 1.23M |
| 487 | LTRN | Lantern Pharma Inc. | 18.16M | - | 341,731 | - |
| 488 | CYCN | Cyclerion Therapeutics, Inc. | 17.54M | -32.52% | 3,067,247 | 2.07M |
| 489 | CUE | Cue Biopharma, Inc. | 17.29M | -1.61% | 1,799,773 | 27.47M |
| 490 | GNTA | Genenta Science S.p.A. | 15.82M | -4.90% | 26,528 | - |
| 491 | HIND | Vyome Holdings, Inc. | 15.16M | 1.41% | 12,058 | 319.71K |
| 492 | PHIO | Phio Pharmaceuticals Corp. | 14.64M | -1.56% | 159,533 | - |
| 493 | LPCN | Lipocine Inc. | 14.16M | -5.37% | 2,676,912 | 1.98M |
| 494 | GTBP | GT Biopharma, Inc. | 14.04M | -1.00% | 339,145 | - |
| 495 | INTS | Intensity Therapeutics, Inc. | 13.95M | -3.68% | 40,016 | - |
| 496 | INAB | IN8bio, Inc. | 13.88M | -2.08% | 61,461 | - |
| 497 | TRAW | Traws Pharma, Inc. | 13.74M | 4.88% | 49,690 | 2.85M |
| 498 | OSRH | OSR Holdings, Inc. | 13.33M | -5.51% | 369,336 | 2.91M |
| 499 | GNPX | Genprex, Inc. | 13.12M | -5.84% | 446,209 | - |
| 500 | BCDA | BioCardia, Inc. | 12.91M | -1.67% | 27,922 | 3.00K |